File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1006/cyto.1999.0512
- Scopus: eid_2-s2.0-0032862515
- PMID: 10525320
- WOS: WOS:000082855700011
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Impaired production of IL-12 in systemic lupus erythematosus. III: Deficient IL-12 p40 gene expression and cross-regulation of IL-12, IL-10 and IFN-γ gene expression
Title | Impaired production of IL-12 in systemic lupus erythematosus. III: Deficient IL-12 p40 gene expression and cross-regulation of IL-12, IL-10 and IFN-γ gene expression |
---|---|
Authors | |
Keywords | Cytokines Gene expression IL-12 Lupus |
Issue Date | 1999 |
Publisher | Academic Press. The Journal's web site is located at http://www.elsevier.com/locate/cytokine |
Citation | Cytokine, 1999, v. 11 n. 10, p. 805-811 How to Cite? |
Abstract | Interleukin 12 (IL-12) is a heterodimer comprising p35 and p40 subunits which are encoded and regulated separately. The authors previously demonstrated deficient IL-12 production in SLE which correlates negatively with disease activity. The present study was designed to determine whether deficiency of IL-12 and excess production of IL-10 and IL-6 in systemic lupus erythematosus (SLE) are due to aberrant regulation at the gene level. Using semiquantitative RT-PCR assay, it was shown that constitutive expression of IL-12 p35 gene is somewhat impaired in SLE compared with controls and that IL-12 p40 mRNA, which was present at low levels in controls, was undetectable in unstimulated SLE peripheral blood mononuclear cells (PBMC). Gene expression of IL-12 p35 and p40 was significantly increased in response to SAC, with significantly lower SAC-induced expression of p40 in SLE patients than controls. SAC-stimulated IL-12 p35 and p40 mRNAs were significantly augmented by interferon γ (IFN-γ). Exogenous IL-12 or IFN-γ significantly inhibited IL-10 gene expression, without affecting IL-6 mRNA or other proinflammatory cytokine mRNA levels. These observations were further confirmed by studies of protein production at the single cell level using ELISPOT assay. Downregulation of IL-12 p40 expression appears to be the cause of IL-12 p70 deficiency in SLE. If this defect could be repaired, normalization of IL-12 and IFN-γ production should reduce excessive IL-10 and prevent pathology. |
Persistent Identifier | http://hdl.handle.net/10722/148150 |
ISSN | 2023 Impact Factor: 3.7 2023 SCImago Journal Rankings: 0.970 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Liu, TF | en_US |
dc.contributor.author | Jones, BM | en_US |
dc.contributor.author | Wong, RWS | en_US |
dc.contributor.author | Srivastava, G | en_US |
dc.date.accessioned | 2012-05-29T06:11:07Z | - |
dc.date.available | 2012-05-29T06:11:07Z | - |
dc.date.issued | 1999 | en_US |
dc.identifier.citation | Cytokine, 1999, v. 11 n. 10, p. 805-811 | en_US |
dc.identifier.issn | 1043-4666 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/148150 | - |
dc.description.abstract | Interleukin 12 (IL-12) is a heterodimer comprising p35 and p40 subunits which are encoded and regulated separately. The authors previously demonstrated deficient IL-12 production in SLE which correlates negatively with disease activity. The present study was designed to determine whether deficiency of IL-12 and excess production of IL-10 and IL-6 in systemic lupus erythematosus (SLE) are due to aberrant regulation at the gene level. Using semiquantitative RT-PCR assay, it was shown that constitutive expression of IL-12 p35 gene is somewhat impaired in SLE compared with controls and that IL-12 p40 mRNA, which was present at low levels in controls, was undetectable in unstimulated SLE peripheral blood mononuclear cells (PBMC). Gene expression of IL-12 p35 and p40 was significantly increased in response to SAC, with significantly lower SAC-induced expression of p40 in SLE patients than controls. SAC-stimulated IL-12 p35 and p40 mRNAs were significantly augmented by interferon γ (IFN-γ). Exogenous IL-12 or IFN-γ significantly inhibited IL-10 gene expression, without affecting IL-6 mRNA or other proinflammatory cytokine mRNA levels. These observations were further confirmed by studies of protein production at the single cell level using ELISPOT assay. Downregulation of IL-12 p40 expression appears to be the cause of IL-12 p70 deficiency in SLE. If this defect could be repaired, normalization of IL-12 and IFN-γ production should reduce excessive IL-10 and prevent pathology. | en_US |
dc.language | eng | en_US |
dc.publisher | Academic Press. The Journal's web site is located at http://www.elsevier.com/locate/cytokine | en_US |
dc.relation.ispartof | Cytokine | en_US |
dc.subject | Cytokines | - |
dc.subject | Gene expression | - |
dc.subject | IL-12 | - |
dc.subject | Lupus | - |
dc.subject.mesh | Cells, Cultured | en_US |
dc.subject.mesh | Dimerization | en_US |
dc.subject.mesh | Gene Expression Regulation - Drug Effects | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Interferon-Gamma - Analysis - Genetics - Pharmacology | en_US |
dc.subject.mesh | Interleukin-10 - Analysis - Genetics | en_US |
dc.subject.mesh | Interleukin-12 - Analysis - Chemistry - Genetics - Pharmacology | en_US |
dc.subject.mesh | Leukocytes, Mononuclear - Drug Effects - Immunology - Metabolism - Pathology | en_US |
dc.subject.mesh | Lupus Erythematosus, Systemic - Genetics - Immunology - Metabolism - Pathology | en_US |
dc.subject.mesh | Molecular Weight | en_US |
dc.subject.mesh | Rna, Messenger - Genetics - Metabolism | en_US |
dc.subject.mesh | Reverse Transcriptase Polymerase Chain Reaction | en_US |
dc.subject.mesh | Staphylococcus Aureus - Immunology | en_US |
dc.title | Impaired production of IL-12 in systemic lupus erythematosus. III: Deficient IL-12 p40 gene expression and cross-regulation of IL-12, IL-10 and IFN-γ gene expression | en_US |
dc.type | Article | en_US |
dc.identifier.email | Srivastava, G: gopesh@pathology.hku.hk | en_US |
dc.identifier.authority | Srivastava, G=rp00365 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1006/cyto.1999.0512 | en_US |
dc.identifier.pmid | 10525320 | - |
dc.identifier.scopus | eid_2-s2.0-0032862515 | en_US |
dc.identifier.hkuros | 52627 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0032862515&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 11 | en_US |
dc.identifier.issue | 10 | en_US |
dc.identifier.spage | 805 | en_US |
dc.identifier.epage | 811 | en_US |
dc.identifier.isi | WOS:000082855700011 | - |
dc.publisher.place | United Kingdom | en_US |
dc.customcontrol.immutable | sml 130621 | - |
dc.identifier.issnl | 1043-4666 | - |